Veracyte (VCYT) Tops Q4 EPS by 7c, Revenues Beat; Offers FY19 Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Veracyte (VCYT) Tops Q4 EPS by 7c, Revenues Beat; Offers FY19 Revenue Guidance Above Consensus

Veracyte, Inc (VCYT) PT Raised to $23 at BTIG

February 26, 2019 8:49 AM EST

BTIG analyst Sung Ji Nam raised the price target on Veracyte, Inc (NASDAQ: VCYT) to $23.00 (from $17.00) while maintaining a Buy rating, citing continued strong momentum for product portfolio.

The analyst commented, "VCYT capped off 2018 on a strong note with full year revenue growth of +28% (vs. initial guidance of +13-15%) and cash burn of $15.4mm, +39% improvement y/y (vs. initial guidance of $18-22mm, +20% improvement at... More